Industry plays a vital role in the cancer research enterprise, and the AACR’s industry partners increased their critical support of its programs and initiatives in 2018. The AACR’s Sustaining Member program expanded to a total of 26 corporate partners, and two longtime AACR supporters made substantial financial commitments to advance the AACR’s mission:
Mark Schoneveld was diagnosed with grade III anaplastic astrocytoma in 2013. After two brain surgeries, proton therapy, and a course of chemotherapy, he has been cancer free for nearly four years. A stay-at-home dad to son Soren and twins Mira and River, Mark focuses on each day, running to stay healthy in the face of a disease that may return some day.
Mark began working with the AACR as an Ambassador in 2018, and he ran in the 2018 AACR Philadelphia Marathon as part of the AACR Runners for Research team to raise money to support lifesaving cancer science:
“The piece of the disease that hits me every day is that this day matters, because I’m alive and I can talk and I can walk and I can run.
I know the promise of research and how it benefits cancer patients today like me. And I want to support cancer researchers in any way I can.”
Video: Learn more about Mark’s story.
Since 2016, MPM Capital has managed the UBS Oncology Impact Fund (OIF). The fund, which invests across a spectrum of companies that develop transformative cancer therapeutics, is the first social impact fund to dedicate a portion of its profits specifically to cancer research. At the AACR Annual Meeting in April, MPM announced that it had selected the AACR as a beneficiary of the OIF, beginning with a $1.2 million gift to establish the AACR-MPM Transformative Research Grants Program. The grants, which will be awarded by a Scientific Advisory Board established by the AACR, will support innovative research that accelerates breakthroughs against cancer.
While its industry partnerships continue to raise the AACR’s national and international profile, the AACR Foundation maintains a strong presence in its home city of Philadelphia—raising funds locally to support the AACR’s mission.
In 2017, the AACR legacy giving society was renamed in honor of Bayard D. Clarkson, MD, FAACR—past president, fifty-year AACR member, Fellow of the AACR Academy, and founding chair of the AACR Foundation. Inspired by Dr. Clarkson’s lifetime of service to the AACR’s mission, a record number of AACR members made an endowed, estate, or other planned gift to benefit the AACR in 2018. Their generous support will sustain the AACR’s ongoing pursuit of its mission to prevent and cure all cancers.
Annual giving offers all donors an opportunity to support lifesaving cancer research and sustain the mission of the AACR. We gratefully acknowledge those individuals and family foundations who gave $500 or more, and those special events, associations, corporations, and foundations that contributed $5,000 or more during the calendar year.
1907 AACR Founders Society
AACR Foundation donors whose cumulative (lifetime) giving exceeds $1,000,000.
The Medaled Society
AACR Foundation donors whose cumulative (lifetime) giving totals $50,000 to $999,999
We gratefully acknowledge the following individuals who have made an endowed, estate, or other planned gift to the American Association for Cancer Research. Creative gift planning provides an opportunity to make a meaningful commitment, maximize philanthropic objectives, and receive important tax benefits.
All those who have established an estate or other planned gift to the AACR, such as a bequest naming the AACR in their will, are recognized with membership in the Dr. Bayard D. Clarkson Legacy Society. This society honors individuals who have invested in sustaining the future of the AACR and its initiatives so that generations to come may benefit from the leadership and groundbreaking work of the AACR and its membership.
The AACR Sustaining Membership Program is a support mechanism that engages industry partners in the AACR’s mission-based activities year-round.